Edit
EdiGene Inc.
http://edi-gene.com/Last activity: 11.04.2019
Active - Reference to Modalis Therapeutics
Transformative gene modulation platform with its proprietary, multi-functional Cas proteins. Spin-out from Univ of Tokyo. IPOed in 2020
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | Fast Track... | fti-jp.com |
| - | Fast Track... | us.fasttra... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.04.2019 | Series B | $15M | - |
| 08.08.2018 | Series B | $15M | - |
Mentions in press and media 4
| Date | Title | Description |
| 11.04.2019 | Insurance Tech Startup Lemonade Raises $300 Million in Funding: Term Sheet for Thursday, April 11 | MAKING LEMONADE Softbank is doubling down on Lemonade. Paid Content You can't secure what you can't see From ExtraHop Here’s how Fortune described the startup in 2016: It pools insurance premiums from people who know and trust one another. ... |
| 10.04.2019 | Daily funding roundup - April 10th, 2019 | Cullgen received $16M; CleverTap raised $26M; Shift secured $40M; ShopBack landed $45M Bump: Bump is a streetwear iOS marketplace app. Bump has raised $7.5 million in Series A funding led by e.ventures, with participation from Kleiner Perki... |
| 10.04.2019 | EdiGENE Raises $15M in Series B Funding | EdiGENE, a Tokyo, Japan based biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, raised 1.6 Billion-yen (approx. $15M) as the first tranche of Series B round. Participants included new investors ... |
| 08.08.2018 | Genome Editing Biotech Company EdiGene Raises $15M in Series Pre-B Round | EdiGene Inc., a Beijing, China-based genome editing biotech company, raised approximately $15M in a Series pre-B financing. The round was led by new investor Lilly Asia Ventures (LAV) with participation from new investor Huagai Capital and ... |